NTP464 | Search

Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

24 results for “NTP464”

Trials

View all 14 →

NTI164 Human PK Study

12 participants · First posted Dec 3, 2024

Study of AFP464 +/- Faslodex in ER + Breast Cancer

7 participants · First posted Nov 3, 2010

Not yet recruiting

NTI164 in Autism Spectrum Disorder

98 participants · First posted Dec 2, 2025

Drugs

[11C]-NOP46

NKp46 NKCE

Universal Dual-target NKG2D-NKp44 CAR-T Cells(Zhejiang University)

News

Nucleome Therapeutics Advances First-in-Class Inflammation Resolution Antibody to Preclinical Development

Nucleome Therapeutics Secures US Patent for Micro Capture-C 3D Genomics Platform, Advancing First-in-Class Inflammatory Disease Pipeline

Neurotech International's NTI164 Shows Promise in Pediatric Neurological Disorders

Page 1 of 3